Related references
Note: Only part of the references are listed.MicroRNAs in kidney physiology and disease
Piera Trionfini et al.
NATURE REVIEWS NEPHROLOGY (2015)
Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes
Cristina Martinez-Garcia et al.
PLOS ONE (2015)
Identification of Novel Long Noncoding RNAs Associated with TGF-β/Smad3-Mediated Renal Inflammation and Fibrosis by RNA Sequencing
Qin Zhou et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
Christoph Wanner et al.
KIDNEY INTERNATIONAL (2014)
The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?
Marcel H. A. Muskiet et al.
NATURE REVIEWS NEPHROLOGY (2014)
Lipid biology of the podocyte-new perspectives offer new opportunities
Alessia Fornoni et al.
NATURE REVIEWS NEPHROLOGY (2014)
Signal transduction in podocytes-spotlight on receptor tyrosine kinases
Jochen Reiser et al.
NATURE REVIEWS NEPHROLOGY (2014)
Statins in chronic kidney disease and kidney transplantation
Theodoros I. Kassimatis et al.
PHARMACOLOGICAL RESEARCH (2014)
Regulation of the Apolipoprotein Gene Cluster by a Long Noncoding RNA
Paul Halley et al.
CELL REPORTS (2014)
Lipid mediators in diabetic nephropathy
Swayam Prakash Srivastava et al.
FIBROGENESIS & TISSUE REPAIR (2014)
Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2
Kapil Kampe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials
Dragana Nikolic et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Afshin Parsa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nephropathy
M. Lucrecia Alvarez et al.
PLOS ONE (2013)
New Insights Into Human Minimal Change Disease: Lessons From Animal Models
Sumant S. Chugh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Genome Regulation by Long Noncoding RNAs
John L. Rinn et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 81 (2012)
Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model
Cristina Martinez-Garcia et al.
DISEASE MODELS & MECHANISMS (2012)
The role of nuclear receptors in the kidney in obesity and metabolic syndrome
Claudia Tovar-Palacio et al.
GENES AND NUTRITION (2012)
The Role of Statins in Chronic Kidney Disease
Rigas G. Kalaitzidis et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Functional Characterization of the Plasmacytoma Variant Translocation 1 Gene (PVT1) in Diabetic Nephropathy
M. Lucrecia Alvarez et al.
PLOS ONE (2011)
Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis
Alessia Fornoni et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Targeting podocyte-associated diseases
Jan Willem Leeuwis et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
PPARα agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity
Xiaoyang Hou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - An allostatic perspective
Sam Virtue et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function
Gavin I. Welsh et al.
CELL METABOLISM (2010)
Renal lipid metabolism and lipotoxicity
Ion Alexandru Bobulescu
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
Xiaoxin X. Wang et al.
DIABETES (2010)
Lipotoxicity in renal proximal tubular cells: Relationship between endoplasmic reticulum stress and oxidative stress pathways
Elias Katsoulieris et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Targeted transfection increases siRNA uptake and gene silencing of primary endothelial cells in vitro - A quantitative study
Sigridur A. Asgeirsdottir et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes
Mervi E. Hyvonen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Giulio Genovese et al.
SCIENCE (2010)
Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids
Jonas Sieber et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Lipid-Protein Interactions along the Slit Diaphragm of Podocytes
Bernhard Schermer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy
Rachel Lennon et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Peroxisome Proliferator-Activated Receptor Gamma Agonists in Kidney Disease - Future Promise, Present Fears
Zhiguo Mao et al.
NEPHRON CLINICAL PRACTICE (2009)
M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy.
Laurence H. Beck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney
Won Suk An et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Anti-α8 Integrin Immunoliposomes in Glomeruli of Lupus-Susceptible Mice A Novel System for Delivery of Therapeutic Agents to the Renal Glomerulus in Systemic Lupus Erythematosus
Yogesh Scindia et al.
ARTHRITIS AND RHEUMATISM (2008)
It's Not How Fat You Are, It's What You Do with It That Counts.
Samuel Virtue et al.
PLOS BIOLOGY (2008)
Adipogenesis and lipotoxicity:: role of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγcoactivator-1 (PGC1)
Gema Medina-Gomez et al.
PUBLIC HEALTH NUTRITION (2007)
Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet
Shinji Kume et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy
Tao Jiang et al.
DIABETES (2007)
PPAR-γ agonist protects podocytes from injury
T. Kanjanabuch et al.
KIDNEY INTERNATIONAL (2007)
Prolonged treatment of primary Hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase
Hui-Yu Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism
Gema Medina-Gomez et al.
PLOS GENETICS (2007)
The complex role of PPARγ in renal dysfunction in obesity:: Managing a Janus-faced receptor
Anca Dana Dobrian
VASCULAR PHARMACOLOGY (2006)
Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content
Clinton R. Bruce et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Immunoliposome targeting to mesangial cells: A promising strategy for specific drug delivery to the kidney
G Tuffin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The role of reactive oxygen species in insulin signaling in the vasculature
GD Frank et al.
ANTIOXIDANTS & REDOX SIGNALING (2005)
Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study
B Becker et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity
JS Cohn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity
AD Dobrian et al.
HYPERTENSION (2004)
Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria
ME Thomas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation
F Zheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria
T Nakamura et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity -: The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study
JM Bard et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Albuminuria and renal injury - beware of proteins bearing gifts
J Iglesias et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells
MC Iglesias-de la Cruz et al.
KIDNEY INTERNATIONAL (2001)
Share Paper
